Urvi Desai
Education
Ph.D., pharmacy administration, Virginia Commonwealth University; B.S. pharmacy, Sardar Patel University
Summary of Experience
Dr. Desai specializes in health economics and outcomes research (HEOR), developing strategic solutions, and assisting with litigation matters in the health care sector. She has designed and managed numerous HEOR studies including cost-of-illness analyses, comparative effectiveness analyses, adherence and persistence evaluations, patient/physician surveys, and pharmacoeconomic modeling. Her work spans several disease areas, including Alzheimer’s disease and related dementias; diabetes; and respiratory illnesses. Dr. Desai’s research has been presented at numerous conferences, and published in peer-reviewed journals including Diabetes Care, Alzheimer’s & Dementia, Health Affairs, and the Journal of Medical Economics, as well as in non-academic outlets such as STAT. She has served as an associate editor for the Journal of Alzheimer's Disease. On the strategy side, Dr. Desai has developed formulary dossiers and presentation materials to assist clients with the commercialization of pharmaceutical products. In her litigation work, she has assisted in several cases in the health care sector involving patent disputes, antitrust issues, and False Claims Act issues. Prior to joining Analysis Group, Dr. Desai was a graduate teaching and research assistant at Virginia Commonwealth University.
-
Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer’s Disease: Findings from a Longitudinal Cohort Analysis
The Journal of Prevention of Alzheimers, 2024
2024Chandler J, Georgieva M, Desai U, Done N, Gomez-Lievano A, Ye W, Zhao A, Eid D, Hilts A, Kirson N, Schilling T
-
Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer’s Disease: Estimates from Real-World Data
The Journal of Prevention of Alzheimer's Disease, 2024
2024Chandler J, Done N, Desai U, Georgieva M, Gomez-Lievano A, Ye W, Zhao A, Eid D, Hilts A, Kirson N, Schilling T
-
Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the Nacc Database
Neurology and Therapy, 2023
2023Chandler J, Georgieva M, Desai U, Kirson N, Lane H, Cheung HC, Westermeyer B, Biglan K
-
Real-World Racial Variation in Treatment and Outcomes among Patients with Peripheral Artery Disease
Advances in Therapy, 2023
2023Ferdinand KC, Sadik K, Browne R, Desai U, Lefebvre P, Lejeune D, Mahendran M, Laliberté F, Matay L, Armstrong DG
-
Unintended Consequences of Increased Out-of-Pocket Costs During Medicare Coverage Gap on Anticoagulant Discontinuation and Stroke
Advances in Therapy, 2023
2023Salam T, Desai U, Lefebvre P, Jian-Yu E, Greatsinger A, Zacharia N, Laliberté F, Bookhart B, Kharat A
-
Real-World Incidence of Adverse Clinical Outcomes Among People With Coronary Artery Disease and/or Peripheral Artery Disease in Relation to Vascular Risk in the United States
The American Journal of Cardiology, 2023
2023Desai U, Babcock A, Wang Y, Akbarnejad H, Wirtz EL, Laliberte F, Lefebvre P, Kharat A
-
The experience of a severe hypoglycaemic event from the perspective of people with diabetes and their caregivers: "What am I going to do?"
Diabetic Medicine, 2022
2022Stuckey HL, Desai U, King SB, Popadic L, Levinson W, Kirson NY, Hankosky ER, Mitchell B
-
Reasons for treatment changes in adults with attention-deficit/hyperactivity disorder: a chart review study
BMC Psychiatry, 2022
2022Schein J, Childress A, Cloutier M, Desai U, Chin A, Simes M, Guerin A, Adams J
-
Epidemiology and economic burden of Lewy body dementia in the United States
Current Medical Research and Opinion, 2022
2022Desai U, Chandler J, Kirson N, Georgieva M, Cheung HC, Westermeyer B, Lane H, Biglan K
-
Cost-per-remitter with esketamine nasal spray versus standard of care for treatment-resistant depression
Journal of Comparative Effectiveness Research, 2021
2021Desai U, Kirson NY, Guglielmo A, Le HH, Spittle T, Tseng-Tham J, Shawi M, Sheehan JJ
-
Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization
Journal of Medical Economics, 2021
2021Desai U, Kharat A, Hess CN, Milentijevic D, Laliberté F, Zuckerman P, Benson J, Lefebvre P, Hiatt WR, Bonaca MP
-
Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization
Annals of Vascular Surgery, 2021
2021Desai U, Kharat A, Hess CN, Milentijevic D, Laliberté F, Zuckerman P, Benson J, Lefebvre P, Hiatt WR, Bonaca MP
-
Overcoming psychological insulin resistance: A practical guide for healthcare professionals
Primary Care Diabetes, 2021
2021Snoek FJ, Fisher L, Polonsky WH, Stuckey H, Hessler D, Tang T, Hermanns N, Mundet X, Silva M, Sturt J, Okazaki K, Hadjiyianni I, Desai U, Perez-Nieves M
-
Successful Health Care Provider Strategies to Overcome Psychological Insulin Resistance in United States and Canada
Journal of the American Board of Family Medicine
2020Tang T, Hessler D, Polonsky WH, Fisher L, Reed B, Irani T, Desai U, Perez-Nieves M
-
Key Strategies for Overcoming Psychological Insulin Resistance in Adults with Type 2 Diabetes: The UK Subgroup in the EMOTION Study
Diabetes Therapy, 2020
2020Balogh EG, Perez-Nieves M, Cao D, Hadjiyianni II, Ashraf N, Desai U, Snoek FJ, Sturt JA
-
Measuring the Impact of Air Pollution on Health Care Costs
Health Affairs, 2020
2020Birnbaum HG, Carley CD, Desai U, Ou S, Zuckerman PR
-
Disease severity at the time of initial cognitive assessment is related to prior health-care resource use burden
Alzheimer's & Dementia, 2020
2020 -
Identifying solutions to psychological insulin resistance: An international study
Journal of Diabetes and its Complications, January 17, 2019
2019Polonsky W, Fisher L, Hessler D, Stuckey Snoeke F, Tang T, Hermanns N, Mundet X, Silva M, Sturt J, Okazaki K, Hadjiyianni I, Cao D, Ivanova J, Desai U, Perez-Nieves M
-
Author’s Contribution: Effect of Delayed Treatment Intensification on Glycemic Control in the Real World
ERICAS Blog, March 19, 2019
2019 -
Temporal and Geographic Variation in the Incidence of Alzheimer’s Disease Diagnosis in the US between 2007 and 2014
Journal of the American Geriatrics Society, December 3, 2019
2019Kirson N, Meadows ES, Desai U, Smith BP, Cheung HC, Zuckerman P, Matthews BR
-
Key factors for overcoming psychological insulin resistance: an examination of patient perspectives through content analysis
BMJ Open Diabetes Research & Care, 2019
2019Stuckey H, Fisher L, Polonsky WH, Hessler D, Snoek FJ, Tang TS, Hermanns N, Mundet-Tuduri X, da Silva MER, Sturt J, Okazaki K, Cao D, Hadjiyianni I, Ivanova JI, Desai U, Perez-Nieves M
-
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
Alzheimer's & Dementia, 2019
2019Andrews JS, Desai U, Kirson NY, Zichlin ML, Ball DE, Matthews BR
-
Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease
Journal of Alzheimer's Disease. Nov 14 2018;61(1):295-307
2018Kirson NY, Scott Andrews J, Desai U, King SB, Schonfeld S, Birnbaum HG, Ball DE, Kahle-Wrobleski K
-
We Need to Improve Medicare’s Annual Wellness Visit to Better Detect Early Dementia
STAT, July 20, 2018
2018 -
Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer's disease diagnosis: a pilot study in England
BMJ Open. Mar 22 2018;8(3):e019684
2018Dell'Agnello G, Desai U, Kirson NY, Wen J, Meiselbach MK, Reed CC, Belger M, Lenox-Smith A, Martinez C, Rasmussen J
-
Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan
Diabetes Therapy. 2018 Jun;9(3):1125-1141
2018Suzuki S, Desai U, Strizek A, Ivanova J, García-Horton V, Cai Z, Schmerold L, Liu X, Perez-Nieves M
-
Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes
Diabetes Care. 2018 Oct;41(10):2096-2104
2018Desai U, Kirson NY, Kim J, Khunti K, King S, Trieschman E, Hellstern M, Hunt PR, Mukherjee J
-
Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer's disease diagnosis: a pilot study in England
BMJ Open. 2018 Mar 22;8(3):e019684
2018Dell'Agnello G, Desai U, Kirson NY, Wen J, Meiselbach MK, Reed CC, Belger M, Lenox-Smith A, Martinez C, Rasmussen J
-
Functional limitations and health care resource utilization for individuals with cognitive impairment without dementia: Findings from a United States population-based survey
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 2017;6:65-74
2017Andrews JS, Desai U, Kirson NY, Enloe CJ, Ristovska L, King S, Birnbaum HG, Fleisher AS, Ye W, Kahle-Wrobleski K
-
Basal Insulin Persistence, Associated Factors, and Outcomes after Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan
Diabetes Therapy. Feb 2017;8(1):149-166
2017Hadjiyianni I, Desai U, Suzuki S, Ivanova JI, Cao D, Kirson NY, Chida D, Enloe C, Birnbaum HG, Perez-Nieves M
-
Burden of systemic glucocorticoid-related complications in severe asthma(1)
Current Medical Research and Opinion. Jan 2017;33(1):57-65
2017Lefebvre P, Duh MS, Lafeuille MH, Gozalo L, Desai U, Robitaille MN, Albers F, Yancey S, Ortega H, Forshag M, Lin X, Dalal AA
-
Burden of systemic glucocorticoid-related complications in severe asthma
Current Medical Research and Opinion, 2016 Oct 14:1-29
2016Lefebvre P, Duh MS, Lafeuille MH, Gozalo L, Desai U, Robitaille MN, Albers F, Yancey S, Ortega H, Forshag M, Lin X, Dalal AA.
-
Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US
Current Medical Research and Opinion, 2016 04; 32(4): 669-680. e-pub ahead of print 2015/12/26
2016Perez-Nieves M, Kabul S, Desai U, Ivanova JI, Kirson NY, Cummings AK, Birnbaum HG, Duan R, Cao D, Hadjiyianni I.
-
Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population
Journal of Alzheimer's Disease, 2016 05. doi: 10.3233/JAD-150685
2016Happich M, Kirson NY, Desai U, King S, Birnbaum HG, Reed C, Belger M, Lenox-Smith A, Price D.